Stryker Corporation (SYK) Financials
PeriodQ2 FY2026
Published
Stryker Corporation reported $6.59 billion in net sales for Q2 FY2026, the quarter ended June 30, 2026, up 9.4% from a year earlier, and net earnings of $1.28 billion, up 44.3%. Earnings grew much faster than sales because gross profit, at $4.50 billion, was up 17.1% from a year earlier, widening gross margin on the reversal of 2025 tariff costs and lower amortization of inventory stepped up to fair value, which carried operating income up 49.1% to $1.66 billion. Diluted earnings per share were $3.30 against $2.29 a year earlier, in a quarter Stryker described as its recovery from the cybersecurity incident that disrupted order processing, manufacturing and shipping in the first quarter of 2026.
| Metric | Amount | vs. year ago |
|---|---|---|
| Net sales | $6,589,000,000 | up 9.4% |
| Net earnings | $1,276,000,000 | up 44.3% |
| Diluted EPS | $3.30 | up 44.1% |
| Operating income | $1,659,000,000 | up 49.1% |
| Gross profit | $4,498,000,000 | up 17.1% |
Company details
| Name | Stryker Corp |
|---|---|
| Ticker | SYK |
| CIK | 0000310764 |
| Exchange | NYSE |
| State | Michigan |
| Incorporation | Michigan |
| SIC | 3841 |
| Office | Industrial Applications and Services |
| Industry | Surgical & Medical Instruments & Apparatus |
| Latest period covered | Q2 FY2026, ended 2026-06-30, 10-Q, accession 0000310764-26-000050 |
| Fiscal year end | 12/31 (MM/DD) |
| Next expected filing | 10-Q around 2026-10-30 (predicted) |
Data files
- Financial statementsPage Annual financial statements plus the latest quarter: income statement, balance sheet, cash flow. Actual dollars, actual shares. Sourcing notes and uncertainties included.
- 10-K and 10-Q summaryPage Qualitative synthesis of the latest 10-K + 10-Q: business, risk factors (quarter-over-quarter changes flagged), MD&A, legal proceedings, subsequent events.
- 8-K filings and eventsPage Digest of material 8-K filings: earnings headlines, management changes, capital-return and financing actions, governance. SEC accession numbers cited throughout.
FAQ · Stryker Q2 FY2026
How much revenue did Stryker report in Q2 FY2026?
Stryker Corporation reported net sales of $6.59 billion for Q2 FY2026, the quarter ended June 30, 2026. That is up 9.4% from $6.02 billion in the same quarter a year earlier.
What was Stryker's net income in Q2 FY2026?
Stryker Corporation reported net earnings of $1.28 billion for Q2 FY2026, the quarter ended June 30, 2026, up 44.3% from $884 million a year earlier.
What was Stryker's earnings per share in Q2 FY2026?
Stryker Corporation earned $3.30 per diluted share in Q2 FY2026, against $2.29 in the same quarter a year earlier, up 44.1%.
Why did Stryker's profit rise faster than sales in Q2 FY2026?
Stryker Corporation's gross profit reached $4.50 billion in Q2 FY2026, up 17.1% from a year earlier while net sales were up 9.4%, as the reversal of 2025 tariff costs and lower amortization of inventory stepped up to fair value widened gross margin. Operating income was $1.66 billion, up 49.1% from $1.11 billion a year earlier.
How fast is Stryker growing?
Stryker Corporation's net sales were $6.59 billion in Q2 FY2026, up 9.4% from $6.02 billion a year earlier, growth the company attributed almost entirely to higher unit volume across both its MedSurg and Neurotechnology and Orthopaedics segments.
Where can I get Stryker Corporation (SYK) financial data in machine-readable form?
Ticker Scout publishes Stryker Corporation's financial statements as JSON at https://tickerscout.ai/syk/financials.json, free, with no API key and no signup. The 10-K and 10-Q narrative and the 8-K events digest are published as Markdown at https://tickerscout.ai/syk/narrative.md and https://tickerscout.ai/syk/events.md. Stryker Corporation's SEC CIK is 0000310764. Every figure cites the SEC accession number it came from, so it can be checked against sec.gov.
When does Stryker Corporation (SYK) next file with the SEC?
Stryker Corporation (SYK) is expected to file its next Form 10-Q with the SEC on or around October 30, 2026. That date is a projection rather than a company-announced date: it is derived from Stryker Corporation's own filing history with the SEC, by taking the date the company filed the same fiscal period a year earlier and adding 52 weeks. The most recent periodic report on file is the 10-Q for Q2 FY2026, the period ended 2026-06-30, SEC accession 0000310764-26-000050.
Related companies
How this page was built
This page was built from Stryker Corporation's own filings with the SEC, read one at a time, and nothing on it is taken from a pre-tagged dataset, a data vendor or another website. The figures are on the company's own fiscal calendar and in actual dollars, as the filings report them. Where the filings do not support a figure, the record says so instead of reporting a zero; this period names six such gaps.
A single company files thousands of pages with the SEC in a year, and no two companies file them the same way, so the reading and the assembly here are done by AI rather than by rules that break on the differences. Every pass is then audited back against the filings it came from before the page is published, and anything the filings do not support is left out and named rather than filled in. AI can still make mistakes. That is why the accession numbers are printed: the filing is the authority, and this page is a route to it.
Published by Ticker Scout, an independent publisher of company filings data. About Ticker Scout · Disclaimer
Data extracted from SEC filings (accession numbers cited in each file). The undated URLs hold the latest period and are replaced in place each quarter; every period also stays published at its own dated URL, which never changes. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.